July 2011

Is Pfizer Barking Up the Wrong Tree?

Is Pfizer Barking Up the Wrong Tree?

Motley Fool

Ista plunges 28% on study failure, downgrades

Ista plunges 28% on study failure, downgrades

Marketwatch

Biotech Revenues Rise, But So Do R&D Cutbacks

Biotech Revenues Rise, But So Do R&D Cutbacks

Pharmalot

5 Pharma Stocks to Buy as Patents Expire

5 Pharma Stocks to Buy as Patents Expire

TheStreet.com

Yervoy hits the market with $95M bang

Yervoy hits the market with $95M bang

Fierce Pharma

5 High Yielding Birth Control Stocks

5 High Yielding Birth Control Stocks

Seeking Alpha

AstraZeneca Settles Most Seroquel Suits

AstraZeneca Settles Most Seroquel Suits

NY Times, NY

Merck to Cut 12% of Workforce, Deepen Savings

Merck to Cut 12% of Workforce, Deepen Savings

Bloomberg

Amgen 2nd-qtr profit falls; revenue rises 4 pct

Amgen 2nd-qtr profit falls; revenue rises 4 pct

Reuters

[video] The Next Big Thing In Biotech: Spectrum

[video] The Next Big Thing In Biotech: Spectrum

TheStreet.com